Cited 2 time in
Comparative analysis between STANDARD-E Covi-FERON ELISA with pre-existing IFN-γ release assays and determination of the optimum cutoff value for assessment of T-Cell response to SARS-CoV-2
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jang, J. | - |
| dc.contributor.author | Widyasari, K. | - |
| dc.contributor.author | Kim, S. | - |
| dc.date.accessioned | 2023-04-26T07:40:41Z | - |
| dc.date.available | 2023-04-26T07:40:41Z | - |
| dc.date.issued | 2023-03 | - |
| dc.identifier.issn | 0887-8013 | - |
| dc.identifier.issn | 1098-2825 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/59310 | - |
| dc.description.abstract | Background: Interferon-gamma (IFN-γ) release assays (IGRAs) are useful for the assessment of the T-cell response to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). We aimed to assess the performance of the newly developed IGRA ELISA test compared to the pre-existing assays and to validate the cutoff value in real-world conditions. Methods: We enrolled 219 participants and assessed agreement between STANDARD-E Covi-FERON ELISA with Quanti-FERON SARS-CoV-2 (QFN SARS-CoV-2), as well as with T SPOT Discovery SARS-CoV-2 based on Cohen's kappa-index. We further determined the optimal cutoff value for the Covi-FERON ELISA according to the immune response to vaccinations or infections. Results: We found a moderate agreement between Covi-FERON ELISA and QFN SARS-CoV-2 before vaccination (kappa-index = 0.71), whereas a weak agreement after the first (kappa-index = 0.40) and second vaccinations (kappa-index = 0.46). However, the analysis between Covi-FERON ELISA and T SPOT assay demonstrated a strong agreement (kappa-index >0.7). The cut-off value of the OS (original spike) marker was 0.759 IU/mL with a sensitivity of 96.3% and specificity of 78.7%, and that of the variant spike (VS) marker was 0.663 IU/mL with a sensitivity and specificity of 77.8% and 80.6%, respectively. Conclusion: The newly determined cut-off value may provide an optimum value to minimize and prevent the occurrence of false-negative or false-positive during the assessment of T-cell immune response using Covi-FERON ELISA under real-world conditions. © 2023 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | John Wiley & Sons Inc. | - |
| dc.title | Comparative analysis between STANDARD-E Covi-FERON ELISA with pre-existing IFN-γ release assays and determination of the optimum cutoff value for assessment of T-Cell response to SARS-CoV-2 | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1002/jcla.24882 | - |
| dc.identifier.scopusid | 2-s2.0-85152257990 | - |
| dc.identifier.wosid | 000966420800001 | - |
| dc.identifier.bibliographicCitation | Journal of Clinical Laboratory Analysis, v.37, no.6 | - |
| dc.citation.title | Journal of Clinical Laboratory Analysis | - |
| dc.citation.volume | 37 | - |
| dc.citation.number | 6 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Medical Laboratory Technology | - |
| dc.relation.journalWebOfScienceCategory | Medical Laboratory Technology | - |
| dc.subject.keywordAuthor | COVID-19 | - |
| dc.subject.keywordAuthor | cutoff value | - |
| dc.subject.keywordAuthor | interferon-gamma | - |
| dc.subject.keywordAuthor | interferon-gamma release assay | - |
| dc.subject.keywordAuthor | kappa-index | - |
| dc.subject.keywordAuthor | T-cell response | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
